Clicks Group Limited

CLCGYOTCHealthcare● Active

$28.90

+$0.52(+1.83%)

Market Cap$3.4B

P/E Ratio—

52W High$44.41

52W Low$28.37

Avg Volume15K

Open$28.91

Beta0.10

PE Ratio Market Cap Forecast

Clicks Group Limited (CLCGY) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

clcgy · pe ratio · data through Aug 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Clicks Group Limited (CLCGY) measures how much investors pay for each dollar of the company's trailing earnings. CLCGY's current PE ratio of 16.45x is calculated by dividing its stock price of $28.90 by its TTM earnings per share of $14.22. −46.8% discount vs 5Y avg 30.9x

16.45x

P/E Ratio (TTM)−46.8%

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-08-31

Forward P/E

N/A

—

Based on 0 analysts

EPS (TTM)

$14.22

TTM · diluted EPS

PEG Ratio

1.36

▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Clicks Group Limited SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2006 – 2025 · Annual

PE Ratio (TTM)

5Y Avg 30.9x

EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

Historical PE Range

Past 20 fiscal years · Front-end computed

Average

22.4x

20-yr mean

Median

24.8x

20-yr midpoint

Minimum

8.4x

Lowest year

Maximum

39.3x

Highest year

16.4x ← Now

8.4x
MinQ1 · 25%24.8x
MedianQ3 · 75%39.3x
Max

Within Historical Range

At 16.45x, CLCGY's current P/E is within its average historical range over the past 20 fiscal years.

30th percentileHigher than 6 of 20 historical fiscal year readings

Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.

PE Ratio vs Peers

Medical - Pharmaceuticals · 6 peers · Annual PE

Company	Market Cap	PE (Annual)	vs Avg	EPS (TTM)
Clicks Group LimitedYou CLCGY	$3.4B	16.45x	-48.2%	$14.22
AddLife AB (publ) ADDLF	$4.9B	84.26x	+165.5%	$4.60
ALK-Abelló A/S AKBLF	$6.3B	42.58x	+34.2%	$5.39
COSMOS Pharmaceutical Corporation CSMYF	$3.3B	16.92x	-46.7%	$390.86
Fielmann AG FLMNF	$4.4B	21.13x	-33.4%	$2.43
Fielmann AG FLMNY	$4.3B	18.62x	-41.3%	$0.47
Gedeon Richter PLC GEDSF	$4.7B	6.89x	-78.3%	$1180.17
Industry Average 6 peers with valid PE	—	31.73x	baseline	—

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 10 of 20 years

Fiscal Year End	PE Ratio	EPS (TTM)	YoY Change
2025-08-31Latest FY2025	28.13x	$26.57	-11.0%
2024-08-31 FY2024	31.62x	$23.83	+18.2%
2023-08-31 FY2023	26.76x	$20.85	-6.8%
2022-08-31 FY2022	28.71x	$21.60	-26.9%
2021-08-31 FY2021	39.26x	$14.88	+23.2%
2020-08-31 FY2020	31.87x	$15.03	+9.9%
2019-08-31 FY2019	29.01x	$13.67	-18.2%
2018-08-31 FY2018	35.47x	$11.55	+28.2%
2017-08-31 FY2017	27.66x	$10.80	+5.2%
2016-08-31 FY2016	26.30x	$9.21	+12.8%

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

PE Ratio = Stock Price ÷ EPS (TTM)

= $28.90 ÷ $14.22 = 16.45x

TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures

Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year

PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium

Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Price history Financial statements Earnings

Frequently asked questions

CLCGY pe ratio · 6 questions

CLCGY's current PE ratio is 16.45x as of 2026-06-09, based on a stock price of $28.90 and TTM EPS of $14.22. Data sourced from Financial Modeling Prep via CLCGY's SEC 10-K and 10-Q filings.

CLCGY PE ratioWhat is CLCGY PE ratioCurrent PE ratio of CLCGYCLCGY PE ratio today

▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Clicks Group Limited SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09